# Krystal Biotech, Inc.: filings

KRYS · Nasdaq · CIK 1711279 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/krys.md) · [Financials](/companies/krys/financials.md) · [Filings](/companies/krys/filings.md) · [Insiders](/companies/krys/insiders.md)

## Reports and events: 160 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 160, 8-K 110, 144 56, SC 13G/A 35, 10-Q 27, 3 18, SC 13G 15, 424B5 10, 10-K 9, DEF 14A 9, DEFA14A 8, CORRESP 7, 3/A 6, S-8 5, UPLOAD 5, 424B2 3, S-3ASR 3, SCHEDULE 13G/A 3, 8-K/A 2, ARS 2, EFFECT 2, S-1/A 2, 424B4 1, 5 1, 8-A12B 1, CERTNAS 1, D 1, DRS 1, DRSLTR 1, S-1 1, S-1MEF 1, S-3 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-15 | 07:02 ET | [8-K](/filings/0001711279-26-000064.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001711279-26-000064 |
| 2026-08-03 | 07:04 ET | [8-K](/filings/0001711279-26-000058.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001711279-26-000058 |
| 2026-08-03 | 07:03 ET | [10-Q](/filings/0001711279-26-000057.md) | Quarterly report, period 2026-06-30 | 0001711279-26-000057 |
| 2026-07-21 | 17:24 ET | [8-K](/filings/0001711279-26-000050.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001711279-26-000050 |
| 2026-05-20 | 20:08 ET | [8-K](/filings/0001711279-26-000047.md) | 5.07 Shareholder vote results | 0001711279-26-000047 |
| 2026-05-04 | 07:07 ET | [8-K](/filings/0001711279-26-000044.md) | 9.01 Financial statements and exhibits | 0001711279-26-000044 |
| 2026-05-04 | 07:06 ET | [10-Q](/filings/0001711279-26-000043.md) | Quarterly report, period 2026-03-31 | 0001711279-26-000043 |
| 2026-04-03 | 16:31 ET | [DEF 14A](/filings/0001711279-26-000036.md) | Proxy statement, period 2026-04-03 | 0001711279-26-000036 |
| 2026-02-17 | 07:06 ET | [8-K](/filings/0001711279-26-000018.md) | 2.02 Results of operations | 0001711279-26-000018 |
| 2026-02-17 | 07:05 ET | [10-K](/filings/0001711279-26-000016.md) | Annual report, period 2025-12-31 | 0001711279-26-000016 |
| 2026-01-12 | 07:50 ET | [8-K](/filings/0001711279-26-000008.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001711279-26-000008 |
| 2026-01-08 | 16:35 ET | [8-K](/filings/0001711279-26-000005.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001711279-26-000005 |
| 2025-12-23 | 16:51 ET | [8-K](/filings/0001711279-25-000092.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001711279-25-000092 |
| 2025-11-03 | 07:04 ET | [8-K](/filings/0001711279-25-000088.md) | 2.02 Results of operations | 0001711279-25-000088 |
| 2025-11-03 | 07:03 ET | [10-Q](/filings/0001711279-25-000087.md) | Quarterly report, period 2025-09-30 | 0001711279-25-000087 |
| 2025-10-22 | 08:01 ET | [8-K](/filings/0001711279-25-000082.md) | 8.01 Other events | 0001711279-25-000082 |
| 2025-08-04 | 07:09 ET | [8-K](/filings/0001711279-25-000078.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001711279-25-000078 |
| 2025-08-04 | 07:04 ET | [10-Q](/filings/0001711279-25-000077.md) | Quarterly report, period 2025-06-30 | 0001711279-25-000077 |
| 2025-07-25 | 09:03 ET | [8-K](/filings/0001711279-25-000071.md) | 7.01 Regulation FD disclosure | 0001711279-25-000071 |
| 2025-07-24 | 16:45 ET | [8-K](/filings/0001711279-25-000069.md) | 7.01 Regulation FD disclosure | 0001711279-25-000069 |
| 2025-07-09 | 09:01 ET | [8-K](/filings/0001711279-25-000065.md) | 7.01 Regulation FD disclosure | 0001711279-25-000065 |
| 2025-06-02 | 17:12 ET | [8-K](/filings/0001711279-25-000055.md) | 8.01 Other events | 0001711279-25-000055 |
| 2025-05-19 | 17:06 ET | [8-K](/filings/0001711279-25-000051.md) | 5.07 Shareholder vote results | 0001711279-25-000051 |
| 2025-05-13 | 18:31 ET | [8-K](/filings/0001711279-25-000048.md) | 7.01 Regulation FD disclosure | 0001711279-25-000048 |
| 2025-05-06 | 08:09 ET | [8-K](/filings/0001711279-25-000045.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001711279-25-000045 |
| 2025-05-06 | 08:08 ET | [10-Q](/filings/0001711279-25-000044.md) | Quarterly report, period 2025-03-31 | 0001711279-25-000044 |
| 2025-05-06 | 18:58 ET | [8-K](/filings/0001711279-25-000037.md) | 7.01 Regulation FD disclosure | 0001711279-25-000037 |
| 2025-04-28 | 08:53 ET | [8-K](/filings/0001711279-25-000029.md) | 7.01 Regulation FD disclosure | 0001711279-25-000029 |
| 2025-04-03 | 16:38 ET | [DEF 14A](/filings/0001711279-25-000021.md) | Proxy statement, period 2025-04-03 | 0001711279-25-000021 |
| 2025-02-28 | 16:53 ET | [8-K](/filings/0001711279-25-000013.md) | 9.01 Financial statements and exhibits | 0001711279-25-000013 |
| 2025-02-19 | 07:25 ET | [8-K](/filings/0001711279-25-000009.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001711279-25-000009 |
| 2025-02-19 | 07:19 ET | [10-K](/filings/0001711279-25-000008.md) | Annual report, period 2024-12-31 | 0001711279-25-000008 |
| 2024-12-18 | 08:39 ET | [8-K](/filings/0001711279-24-000065.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001711279-24-000065 |
| 2024-12-12 | 08:30 ET | [8-K](/filings/0001711279-24-000062.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001711279-24-000062 |
| 2024-11-04 | 08:05 ET | [10-Q](/filings/0001711279-24-000056.md) | Quarterly report, period 2024-09-30 | 0001711279-24-000056 |
| 2024-11-04 | 08:04 ET | [8-K](/filings/0001711279-24-000055.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001711279-24-000055 |
| 2024-08-28 | 16:31 ET | [8-K](/filings/0001711279-24-000045.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001711279-24-000045 |
| 2024-08-05 | 08:08 ET | [10-Q](/filings/0001711279-24-000040.md) | Quarterly report, period 2024-06-30 | 0001711279-24-000040 |
| 2024-08-05 | 08:03 ET | [8-K](/filings/0001711279-24-000038.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001711279-24-000038 |
| 2024-05-21 | 16:38 ET | [8-K](/filings/0001711279-24-000027.md) | 5.07 Shareholder vote results | 0001711279-24-000027 |
| 2024-05-08 | 19:06 ET | [8-K](/filings/0001711279-24-000023.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001711279-24-000023 |
| 2024-05-06 | 08:17 ET | [10-Q](/filings/0001711279-24-000020.md) | Quarterly report, period 2024-03-31 | 0001711279-24-000020 |
| 2024-05-06 | 08:04 ET | [8-K](/filings/0001711279-24-000018.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001711279-24-000018 |
| 2024-04-04 | 16:08 ET | [DEF 14A](/filings/0001711279-24-000013.md) | Proxy statement, period 2024-04-04 | 0001711279-24-000013 |
| 2024-02-26 | 08:04 ET | [8-K](/filings/0001711279-24-000009.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001711279-24-000009 |
| 2024-02-26 | 07:49 ET | [10-K](/filings/0001711279-24-000005.md) | Annual report, period 2023-12-31 | 0001711279-24-000005 |
| 2023-11-06 | 07:10 ET | [8-K](/filings/0001711279-23-000074.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001711279-23-000074 |
| 2023-11-06 | 07:08 ET | [10-Q](/filings/0001711279-23-000073.md) | Quarterly report, period 2023-09-30 | 0001711279-23-000073 |
| 2023-08-07 | 08:18 ET | [8-K](/filings/0001711279-23-000069.md) | 5.02 Departure or appointment of officers or directors | 0001711279-23-000069 |
| 2023-08-07 | 07:13 ET | [8-K](/filings/0001711279-23-000067.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001711279-23-000067 |

Page 1 of 4. [Older](/companies/krys/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 13:54 ET. No prices; not investment advice.